TEVA logo

TEVA Selling, General & Administrative Expenses

Annual SGA

$3.70 B
+$204.00 M+5.83%

December 31, 2024

Summary

Performance

1-Year Change

+5.83%

3-Year Change

+4.93%

5-Year Change

-2.73%

15-Year Change

-23.61%

TEVA SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

97.24%
TEVA annual SGA is higher than 97.24% of companies in Healthcare sector

High & Low

All-time High

$5.32 B
TEVA annual SGA is currently -30.40% below its historical high of $5.32 billion

3-Year Low

$3.44 B
TEVA annual SGA is currently +7.46% above its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
TEVA previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
TEVA next annual earnings announcement has not yet been scheduled

OtherTEVAexpensesmetrics:

Annual Total Expenses

$13.18 B
TEVA annual total expenses is $13.18 billion

Annual Operating Expenses

$4.70 B
TEVA annual total operating expenses is $4.70 billion

Annual Cost Of Goods Sold

$8.48 B
TEVA annual cost of goods sold is $8.48 billion

Annual Interest Expense

$915.00 M
TEVA annual interest expense is $915.00 million

Quarterly SGA

$952.00 M
+$28.00 M+3.03%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+7.45%

3-Year Change

+4.96%

5-Year Change

-5.74%

TEVA Quarterly SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

97.1%
TEVA quarterly SGA is higher than 97.1% of companies in Healthcare sector

High & Low

All-time High

$1.45 B
TEVA quarterly SGA is currently -34.25% below its historical high of $1.45 billion

3-Year Low

$822.00 M
TEVA quarterly SGA is currently +15.82% above its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
TEVA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
TEVA next earnings announcement is scheduled for May 8, 2025

OtherTEVAexpensesmetrics:

Quarterly Total Expenses

$3.31 B
TEVA quarterly total expenses is $3.31 billion

Quarterly Operating Expenses

$1.20 B
TEVA quarterly total operating expenses is $1.20 billion

Quarterly Cost Of Goods Sold

$2.11 B
TEVA quarterly cost of goods sold is $2.11 billion

Quarterly Interest Expense

$224.00 M
TEVA quarterly interest expense is $224.00 million

TTM SGA

N/A

December 31, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

TEVA TTM SGA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$59.94 B
TEVA TTM SGA is currently at an all-time high

3-Year Low

-$56.68 B
TEVA TTM SGA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
TEVA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
TEVA next earnings announcement is scheduled for May 8, 2025

OtherTEVAexpensesmetrics:

Annual Total Expenses

$13.18 B
TEVA annual total expenses is $13.18 billion

Annual Operating Expenses

$4.70 B
TEVA annual total operating expenses is $4.70 billion

TTM Cost Of Goods Sold

$8.48 B
TEVA TTM cost of goods sold is $8.48 billion

TTM Interest Expense

$987.00 M
TEVA TTM interest expense is $987.00 million

Selling, General & Administrative Expenses Formula

SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development

Annual SGA

$3.70 B
TEVA annual SGA is $3.70 billion

Annual Operating Expenses

$4.70 B
TEVA annual total operating expenses is $4.70 billion

Annual Cost Of Goods Sold

$8.48 B
TEVA annual cost of goods sold is $8.48 billion

TEVA Selling, General & Administrative Expenses Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+5.8%+7.5%-
3 y3 years+4.9%+5.0%-
5 y5 years-2.7%-5.7%-

TEVA Selling, General & Administrative Expenses Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+7.5%at high+15.8%
5 y5-year-2.7%+7.5%-7.1%+15.8%
alltimeall time-30.4%>+9999.0%-34.3%+1934.2%

Teva Pharmaceutical Industries Limited Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Dec 2024
$3.70 B(+5.8%)
$952.00 M(+3.0%)
$3.70 B(+1.4%)
Sep 2024
-
$924.00 M(-1.6%)
$3.65 B(+2.2%)
Jun 2024
-
$939.00 M(+6.0%)
$3.57 B(+0.8%)
Mar 2024
-
$886.00 M(-1.8%)
$3.54 B(+1.3%)
Dec 2023
$3.50 B(+1.5%)
$902.00 M(+6.9%)
$3.50 B(+1.9%)
Sep 2023
-
$844.00 M(-7.3%)
$3.43 B(+0.6%)
Jun 2023
-
$910.00 M(+8.1%)
$3.41 B(+0.1%)
Mar 2023
-
$842.00 M(+0.6%)
$3.41 B(-1.1%)
Dec 2022
$3.44 B(-2.4%)
$837.00 M(+1.8%)
$3.45 B(-2.0%)
Sep 2022
-
$822.00 M(-9.4%)
$3.52 B(-1.8%)
Jun 2022
-
$907.00 M(+3.1%)
$3.58 B(+1.4%)
Mar 2022
-
$880.00 M(-3.1%)
$3.53 B(+0.1%)
Dec 2021
$3.53 B(-3.9%)
$908.00 M(+2.3%)
$3.53 B(-2.8%)
Sep 2021
-
$888.00 M(+3.6%)
$3.63 B(+0.1%)
Jun 2021
-
$857.00 M(-2.1%)
$3.63 B(-0.1%)
Mar 2021
-
$875.00 M(-13.4%)
$3.63 B(-1.1%)
Dec 2020
$3.67 B(-3.5%)
$1.01 B(+14.3%)
$3.67 B(-0.4%)
Sep 2020
-
$884.00 M(+2.7%)
$3.69 B(+0.1%)
Jun 2020
-
$861.00 M(-6.1%)
$3.68 B(-2.7%)
Mar 2020
-
$917.00 M(-10.5%)
$3.78 B(-0.6%)
Dec 2019
$3.81 B(-9.7%)
$1.02 B(+16.5%)
$3.81 B(-3.0%)
Sep 2019
-
$880.00 M(-8.5%)
$3.92 B(-3.2%)
Jun 2019
-
$962.00 M(+2.3%)
$4.05 B(-0.9%)
Mar 2019
-
$940.00 M(-17.6%)
$4.09 B(-3.0%)
Dec 2018
$4.21 B(-13.0%)
$1.14 B(+13.2%)
$4.21 B(+3.5%)
Sep 2018
-
$1.01 B(+1.0%)
$4.07 B(-4.8%)
Jun 2018
-
$998.00 M(-6.5%)
$4.28 B(-6.7%)
Mar 2018
-
$1.07 B(+6.7%)
$4.59 B(-5.3%)
Dec 2017
$4.85 B(-2.6%)
$1.00 B(-17.7%)
$4.85 B(-6.1%)
Sep 2017
-
$1.22 B(-7.0%)
$5.16 B(-0.7%)
Jun 2017
-
$1.31 B(-1.3%)
$5.20 B(+0.9%)
Mar 2017
-
$1.32 B(+0.5%)
$5.15 B(+3.6%)
Dec 2016
$4.97 B(+2.8%)
$1.32 B(+5.4%)
$4.97 B(-0.2%)
Sep 2016
-
$1.25 B(-1.0%)
$4.98 B(+3.2%)
Jun 2016
-
$1.26 B(+10.5%)
$4.83 B(+1.6%)
Mar 2016
-
$1.14 B(-13.9%)
$4.75 B(-1.8%)
Dec 2015
$4.84 B(-4.7%)
$1.33 B(+21.2%)
$4.84 B(+0.0%)
Sep 2015
-
$1.10 B(-7.5%)
$4.84 B(-3.0%)
Jun 2015
-
$1.19 B(-3.6%)
$4.98 B(-0.8%)
Mar 2015
-
$1.23 B(-7.3%)
$5.02 B(-1.1%)
Dec 2014
$5.08 B(-4.5%)
$1.33 B(+6.7%)
$5.08 B(-2.3%)
Sep 2014
-
$1.24 B(+1.6%)
$5.20 B(-0.5%)
Jun 2014
-
$1.22 B(-4.9%)
$5.22 B(-1.5%)
Mar 2014
-
$1.29 B(-11.2%)
$5.30 B(-0.3%)
Dec 2013
$5.32 B(+3.9%)
$1.45 B(+14.2%)
$5.32 B(+1.4%)
Sep 2013
-
$1.27 B(-2.5%)
$5.25 B(+1.2%)
Jun 2013
-
$1.30 B(-0.1%)
$5.18 B(+0.1%)
Mar 2013
-
$1.30 B(-5.2%)
$5.18 B(+1.2%)
Dec 2012
$5.12 B(+16.0%)
$1.37 B(+13.9%)
$5.12 B(+0.5%)
Sep 2012
-
$1.21 B(-7.0%)
$5.09 B(+6.0%)
Jun 2012
-
$1.30 B(+4.6%)
$4.81 B(+4.5%)
Mar 2012
-
$1.24 B(-8.2%)
$4.60 B(+4.2%)
Dec 2011
$4.41 B(+15.1%)
$1.35 B(+47.2%)
$4.41 B(+6.6%)
Sep 2011
-
$918.00 M(-15.6%)
$4.14 B(-1.6%)
Jun 2011
-
$1.09 B(+3.3%)
$4.21 B(+6.5%)
Mar 2011
-
$1.05 B(-2.4%)
$3.95 B(+3.1%)
Dec 2010
$3.83 B(+9.5%)
$1.08 B(+9.3%)
$3.83 B(+2.9%)
Sep 2010
-
$987.00 M(+18.5%)
$3.72 B(+2.9%)
Jun 2010
-
$833.00 M(-10.8%)
$3.62 B(-0.4%)
Mar 2010
-
$934.00 M(-3.7%)
$3.63 B(+3.8%)
DateAnnualQuarterlyTTM
Dec 2009
$3.50 B(+39.3%)
$970.00 M(+9.9%)
$3.50 B(+9.0%)
Sep 2009
-
$883.00 M(+4.4%)
$3.21 B(+7.9%)
Jun 2009
-
$846.00 M(+5.8%)
$2.97 B(+6.3%)
Mar 2009
-
$800.00 M(+17.6%)
$2.80 B(+11.4%)
Dec 2008
$2.51 B(+32.1%)
$680.00 M(+4.9%)
$2.51 B(+6.9%)
Sep 2008
-
$648.00 M(-3.1%)
$2.35 B(+8.8%)
Jun 2008
-
$669.00 M(+30.2%)
$2.16 B(+10.2%)
Mar 2008
-
$514.00 M(-0.8%)
$1.96 B(+3.1%)
Dec 2007
$1.90 B(+20.9%)
$518.00 M(+13.1%)
$1.90 B(+2.2%)
Sep 2007
-
$458.00 M(-2.3%)
$1.86 B(+3.0%)
Jun 2007
-
$469.00 M(+2.9%)
$1.81 B(+5.5%)
Mar 2007
-
$456.00 M(-4.4%)
$1.71 B(+8.9%)
Dec 2006
$1.57 B(+96.7%)
$477.10 M(+18.2%)
$1.57 B(+19.8%)
Sep 2006
-
$403.80 M(+7.5%)
$1.31 B(+16.9%)
Jun 2006
-
$375.50 M(+18.8%)
$1.12 B(+20.7%)
Mar 2006
-
$316.00 M(+45.2%)
$930.40 M(+16.4%)
Dec 2005
$799.00 M(+14.6%)
$217.70 M(+1.7%)
$799.00 M(+3.8%)
Sep 2005
-
$214.00 M(+17.1%)
$769.70 M(+4.4%)
Jun 2005
-
$182.70 M(-1.0%)
$737.20 M(+1.9%)
Mar 2005
-
$184.60 M(-2.0%)
$723.50 M(+3.8%)
Dec 2004
$697.00 M(+33.9%)
$188.40 M(+3.8%)
$697.00 M(+7.0%)
Sep 2004
-
$181.50 M(+7.4%)
$651.30 M(+9.4%)
Jun 2004
-
$169.00 M(+6.9%)
$595.10 M(+7.0%)
Mar 2004
-
$158.10 M(+10.8%)
$556.00 M(+6.8%)
Dec 2003
$520.60 M(+28.1%)
$142.70 M(+13.9%)
$520.60 M(+8.0%)
Sep 2003
-
$125.30 M(-3.5%)
$482.00 M(+3.6%)
Jun 2003
-
$129.90 M(+5.9%)
$465.10 M(+7.2%)
Mar 2003
-
$122.70 M(+17.9%)
$433.90 M(+6.8%)
Dec 2002
$406.40 M(+11.8%)
$104.10 M(-4.0%)
$406.40 M(+1.4%)
Sep 2002
-
$108.40 M(+9.8%)
$400.86 M(+6.4%)
Jun 2002
-
$98.70 M(+3.7%)
$376.66 M(+2.1%)
Mar 2002
-
$95.20 M(-3.4%)
$368.74 M(+1.4%)
Dec 2001
$363.56 M(+18.4%)
$98.56 M(+17.1%)
$363.60 M(+1.3%)
Sep 2001
-
$84.20 M(-7.2%)
$359.04 M(+1.7%)
Jun 2001
-
$90.78 M(+0.8%)
$353.11 M(+5.3%)
Mar 2001
-
$90.06 M(-4.2%)
$335.48 M(+9.2%)
Dec 2000
$307.08 M(+31.3%)
$94.00 M(+20.1%)
$307.08 M(+8.8%)
Sep 2000
-
$78.27 M(+7.0%)
$282.27 M(+8.1%)
Jun 2000
-
$73.14 M(+18.6%)
$261.20 M(+7.6%)
Mar 2000
-
$61.66 M(-10.9%)
$242.85 M(+3.8%)
Dec 1999
$233.89 M(+12.4%)
$69.19 M(+21.0%)
$233.89 M(+6.4%)
Sep 1999
-
$57.20 M(+4.4%)
$219.80 M(-0.0%)
Jun 1999
-
$54.80 M(+4.0%)
$219.90 M(+2.8%)
Mar 1999
-
$52.70 M(-4.4%)
$214.00 M(+2.8%)
Dec 1998
$208.00 M(+5.6%)
$55.10 M(-3.8%)
$208.10 M(+36.0%)
Sep 1998
-
$57.30 M(+17.2%)
$153.00 M(+59.9%)
Jun 1998
-
$48.90 M(+4.5%)
$95.70 M(+104.5%)
Mar 1998
-
$46.80 M
$46.80 M
Dec 1997
$197.00 M(+17.5%)
-
-
Dec 1996
$167.60 M(+15.3%)
-
-
Dec 1995
$145.40 M(+12.1%)
-
-
Dec 1994
$129.70 M(+28.2%)
-
-
Dec 1993
$101.20 M(+22.7%)
-
-
Dec 1992
$82.50 M(+23.0%)
-
-
Dec 1991
$67.10 M(-20.9%)
-
-
Dec 1990
$84.80 M(+51.2%)
-
-
Dec 1989
$56.10 M(+9.4%)
-
-
Dec 1988
$51.30 M(+69.3%)
-
-
Mar 1987
$30.30 M(+78.2%)
-
-
Mar 1986
$17.00 M
-
-

FAQ

  • What is Teva Pharmaceutical Industries Limited annual SGA?
  • What is the all time high annual SGA for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited annual SGA year-on-year change?
  • What is Teva Pharmaceutical Industries Limited quarterly SGA?
  • What is the all time high quarterly SGA for Teva Pharmaceutical Industries Limited?
  • What is Teva Pharmaceutical Industries Limited quarterly SGA year-on-year change?
  • What is the all time high TTM SGA for Teva Pharmaceutical Industries Limited?

What is Teva Pharmaceutical Industries Limited annual SGA?

The current annual SGA of TEVA is $3.70 B

What is the all time high annual SGA for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high annual SGA is $5.32 B

What is Teva Pharmaceutical Industries Limited annual SGA year-on-year change?

Over the past year, TEVA annual SGA has changed by +$204.00 M (+5.83%)

What is Teva Pharmaceutical Industries Limited quarterly SGA?

The current quarterly SGA of TEVA is $952.00 M

What is the all time high quarterly SGA for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high quarterly SGA is $1.45 B

What is Teva Pharmaceutical Industries Limited quarterly SGA year-on-year change?

Over the past year, TEVA quarterly SGA has changed by +$66.00 M (+7.45%)

What is the all time high TTM SGA for Teva Pharmaceutical Industries Limited?

Teva Pharmaceutical Industries Limited all-time high TTM SGA is $59.94 B